Showing results (11-20 of 539) with videos related to
Sort By:
Pageof 54
Plos One|October 12, 2012
Peptide-based subunit vaccine against hookworm infectionMariusz Skwarczynski, Annette M Dougall, Makan Khoshnejad, et al.Plos Neglected Tropical Diseases|August 5, 2016
Compounds Derived from the Bhutanese Daisy, Ajania nubigena, Demonstrate Dual Anthelmintic Activity against Schistosoma mansoni and Trichuris murisPhurpa Wangchuk, Mark S Pearson, Paul R Giacomin, et al.Plos Pathogens|December 7, 2019
Novel cholinesterase paralogs of Schistosoma mansoni have perceived roles in cholinergic signalling and drug detoxification and are essential for parasite survivalBemnet A Tedla, Javier Sotillo, Darren Pickering, et al.Idrugs : the Investigational Drugs Journal|November 25, 2004
Proteolytic Enzymes as Therapeutic Targets - Keystone Symposium. Targeting ICE and ACE. 3-8 February 2002, Keystone, CA, USAAlex LoukasPlos Neglected Tropical Diseases|March 20, 2012
Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2Mark S Pearson, Darren A Pickering, Henry J McSorley, et al.The International Journal of Biochemistry & Cell Biology|November 11, 2008
Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificitySutas Suttiprapa, Jason Mulvenna, Ngo Thi Huong, et al.The Journal of Infectious Diseases|April 7, 2010
Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasisMark S Pearson, Darren A Pickering, Leon Tribolet, et al.Vaccines|July 30, 2020
Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of SchistosomiasisGebeyaw G Mekonnen, Bemnet A Tedla, Darren Pickering, et al.Elife|March 21, 2018
Flatworm-specific transcriptional regulators promote the specification of tegumental progenitors in Schistosoma mansoniGeorge R Wendt, Julie Nr Collins, Jimin Pei, et al.Human Vaccines & Immunotherapeutics|May 29, 2015
New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74Mark S Pearson, Amar R Jariwala, Giovanni Abbenante, et al.Pageof 54